154 related articles for article (PubMed ID: 10899364)
21. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
Smith MA; French AM
Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
[TBL] [Abstract][Full Text] [Related]
22. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Jewett DC; Grace MK; Jones RM; Billington CJ; Portoghese PS; Levine AS
Brain Res; 2001 Aug; 909(1-2):75-80. PubMed ID: 11478923
[TBL] [Abstract][Full Text] [Related]
23. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
Picker MJ; Cook CD
Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
[TBL] [Abstract][Full Text] [Related]
24. Discriminative stimulus effects on enadoline in pigeons.
Brandt MR; France CP
J Pharmacol Exp Ther; 1996 May; 277(2):960-7. PubMed ID: 8627579
[TBL] [Abstract][Full Text] [Related]
25. Monoamine systems in the discriminative effects of spiradoline, a kappa-opioid agonist.
Holtzman SG; Steinfels GF
Pharmacol Biochem Behav; 1994 Mar; 47(3):575-8. PubMed ID: 8208776
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
27. Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures.
Minervini V; Lu HY; Padarti J; Osteicoechea DC; France CP
Psychopharmacology (Berl); 2018 Aug; 235(8):2245-2256. PubMed ID: 29785554
[TBL] [Abstract][Full Text] [Related]
28. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
DeRossett SE; Holtzman SG
J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
[TBL] [Abstract][Full Text] [Related]
29. Interactions between kappa opioid agonists and cocaine. Preclinical studies.
Mello NK; Negus SS
Ann N Y Acad Sci; 2000; 909():104-32. PubMed ID: 10911926
[TBL] [Abstract][Full Text] [Related]
30. Involvement of mesolimbic kappa-opioid systems in the discriminative stimulus effects of morphine.
Spanagel R; Shoaib M
Neuroscience; 1994 Dec; 63(3):797-804. PubMed ID: 7898679
[TBL] [Abstract][Full Text] [Related]
31. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
Holtzman SG
J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
[TBL] [Abstract][Full Text] [Related]
32. Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors.
Suzuki T; Mori T; Tsuji M; Misawa M; Nagase H
Eur J Pharmacol; 1995 Sep; 284(1-2):195-8. PubMed ID: 8549626
[TBL] [Abstract][Full Text] [Related]
33. Serotonin involvement in the discriminative stimulus effects of kappa opioids in pigeons.
Bronson ME; Lin YP; Burchett K; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 1993; 111(1):69-77. PubMed ID: 7870936
[TBL] [Abstract][Full Text] [Related]
34. Discriminative stimulus and response rate-decreasing effects of kappa opioids: antagonism by naloxone.
Picker MJ
Life Sci; 1994; 54(23):1767-75. PubMed ID: 8196490
[TBL] [Abstract][Full Text] [Related]
35. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
Powell KR; Holtzman SG
Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921
[TBL] [Abstract][Full Text] [Related]
36. kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
Vivian JA; DeYoung MB; Sumpter TL; Traynor JR; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1999 Jul; 290(1):259-65. PubMed ID: 10381785
[TBL] [Abstract][Full Text] [Related]
37. Effects of nor-binaltorphimine on butorphanol dependence.
Jaw SP; Makimura M; Hoskins B; Ho IK
Eur J Pharmacol; 1993 Aug; 239(1-3):133-40. PubMed ID: 8223888
[TBL] [Abstract][Full Text] [Related]
38. Central discriminative effects of morphine in rats: training via intracerebroventricular administration.
Easterling KW; Holtzman SG
Brain Res Bull; 2001 Dec; 56(6):545-51. PubMed ID: 11786240
[TBL] [Abstract][Full Text] [Related]
39. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
Takemori AE; Schwartz MM; Portoghese PS
J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the discriminative and neuroendocrine effects of centrally penetrating kappa-opioid agonists in rhesus monkeys.
Butelman ER; Ball JW; Kreek MJ
Psychopharmacology (Berl); 2002 Oct; 164(1):115-20. PubMed ID: 12373425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
